A Nanotherapeutic Agent for Synergistic Tumor Therapy: Co‐Activation of Photochemical‐Biological Effects
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202425631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Junwei Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Henan Normal University. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Research Foundation of Korea.
Abstract (Originalsprache)
Single‐mode photodynamic therapy (PDT) based on photochemical reactions is limited by the tumor microenvironment, which reduces the ablation efficiency for solid tumors. Making it vital to seek ways to improve the tumor therapeutic effect. Based on this, we propose a dual‐mode intelligent nanotherapeutic system (HAP@BMPns) based on photochemical‐biological effects. HAP@BMPns is composed of an acid‐responsive high‐calcium biomimetic nanomaterial (HAP) and photosensitizer (BMP), which can spontaneously activate photochemical (Type‐I PDT) and biological effects for synergistic cancer therapy. HAP@BMPns breaks down upon entering tumor cells under acidic conditions, releasing a large amount of Ca 2+ and BMP. Triggering intracellular Ca 2+ overload, which induces mitochondrial damage, leading to apoptosis. Synchronously, Type‐I PDT of BMP under two‐photon (800 nm) laser irradiation becomes activated, resulting in enhanced destruction of tumor cells by the photochemical effect. Cell studies have indicated that HAP@BMPns (41.6 μg/mL) exhibits a strong inhibitory efficiency on tumor cells growth, with low (22.4 %) survival rate. However, the individual components, i. e. BMP (5.0 μM) and HAP (41.6 μg/mL) display low inhibitory efficiency with high survival rates (55.9 % and 63.0 % respectively). Therefore, this dual‐mode synergistic treatment strategy using acid‐triggered photochemical‐biological effects significantly enhances the ablation of solid tumors, realizing the synergistic effect. We hope that this design strategy can provide guidance for the design and development of a tumor therapeutic platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Henan Normal University.
- Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Normal University, Xinxiang, Henan,…
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Korea.
- College of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan, 453007, P. R. China.
- Department of Chemistry, University of Bath, Bath, BA2 7AY, UK.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, 03760, Korea.
ORCID-Profile: Tony D James, Juyoung Yoon, Hua Zhang
Förderung
- National Natural Science Foundation of China
- National Research Foundation of Korea
Zitieren
APA
Liu, J., Liu, Y., Zhi, S., Yang, Y., Kim, H., Wu, D., Wang, G., James, T. D., Yoon, J., & Zhang, H. (2025). A Nanotherapeutic Agent for Synergistic Tumor Therapy: Co‐Activation of Photochemical‐Biological Effects. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202425631
Vancouver
Liu J, Liu Y, Zhi S, Yang Y, Kim H, Wu D, et al. A Nanotherapeutic Agent for Synergistic Tumor Therapy: Co‐Activation of Photochemical‐Biological Effects. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202425631
BibTeX
@article{Liu2025,
author = {Liu, Junwei and Liu, Yang and Zhi, Songsong and Yang, Yonggang and Kim, Heejeong and Wu, Dapeng and Wang, Ge and James, Tony D and Yoon, Juyoung and Zhang, Hua},
title = {A Nanotherapeutic Agent for Synergistic Tumor Therapy: Co‐Activation of Photochemical‐Biological Effects},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202425631}
}
EUVIMED